Schedule 13D ownership disclosure

NUVATION BIO INC

Security class unavailable · CUSIP: 67080N101

Event date: 2024-09-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,314,083
Percent of class
0.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-098630
Form type
SC 13D
Filer
Decheng Capital China Life Sciences USD Fund III, L.P.
CIK
CIK 1736814
Filed
Sep 10, 2024
Reporting period
Sep 03, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub